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We examined in situ expression of putative hyaluronan
synthase genes, Has1 and Has2, and effects of trans-
forming growth factor-β on their expression. In situ
mRNA hybridization showed that mouse skin expressed
both Has1 and Has2 mRNA in dermis and epidermis. In
dermis, the number of cells expressing the Has1 mRNA
was less than that of the Has2 mRNA, and in epidermis,
some strong signals from both mRNA were seen in
stratum granulosum. Northern blot analysis showed that
cultured human skin fibroblasts expressed Has1 mRNA
of 2.4 kb and Has2 mRNA of 3.2 and 4.8 kb, whereas
human keratinocytes expressed Has1 mRNA of 4.8 but
not 2.4 kb and a trace of Has2 mRNA. When the cultures
were stimulated with transforming growth factor-β, both
Hyaluronan is a high molecular weight linear glycos-aminoglycan of alternating glucuronic acid and N-acetylglucosamine residues and is found in the extracel-lular matrix, especially of connective tissues such asdermis. Hyaluronan has several physiochemical and
biologic functions, such as space filling, lubrication, cell proliferation,
and migration (Laurent and Fraster, 1992).
Skin contains about half of the total body hyaluronan (Laurent and
Reed, 1991). Histologic analysis showed that hyaluronan distributes to
not only dermis but also epidermis (Tammi et al, 1988). Furthermore,
the ability of keratinocytes to synthesize hyaluronan has been reported
in both cell cultures (Brown and Parkinson, 1983; Roberts and Jenner,
1983; Lamberg et al, 1986) and organ cultures (Tammi et al, 1989;
Ueno et al, 1992; Ågren et al, 1995).
Hyaluronan is synthesized at the inner surface of the plasma
membranes as long chains by adding sugar residues at the reducing
end, and then is extruded to the extracellular space (Prehm, 1983,
1984). The hyaluronan synthase activity has been found to localize
exclusively in plasma-membrane fractions of cultured human skin
fibroblasts (Mian, 1986a, b). The synthesis of hyaluronan is stimulated
by growth regulatory factors, such as transforming growth factor-β
(TGF-β), platelet-derived growth factor-BB (PDGF-BB), fibroblast
growth factor, and epidermal growth factor (Heldin et al, 1989, 1992;
Suzuki et al, 1995); however, the exact mechanism and regulation of
hyaluronan biosynthesis remains unclear.
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Has1 and Has2 mRNA were upregulated in fibroblasts,
and only Has1 mRNA of 2.4 but not 4.8 kb was induced
in keratinocytes. The maximal amount of the upregulated
Has1 mRNA in keratinocytes at 2 h after stimulation
decreased time-dependently to the nonstimulated level
at 18 h, although the stimulation for 18 h of fibroblasts
was effective on the expression of both Has mRNA.
Differences in expression pattern of Has and Has2 mRNA
in mouse skin and a higher response of fibroblasts to
transforming growth factor-β suggest that Has1 and
Has2 genes are regulated independently and synthesized
hyaluronan may have a different function in epidermis
and dermis. Key words: fibroblasts/Has1/Has2/keratinocytes.
J Invest Dermatol 110:116–121, 1998
Recently, a cDNA for putative mammalian hyaluronan synthase
(Has) was cloned from mouse mammary carcinoma cells (Itano and
Kimata, 1996a). Subsequently, several groups have cloned the cDNA
for human (Itano and Kimata, 1996b; Watanabe and Yamaguchi, 1996;
Shyjian et al, 1996) and mouse (Spicer et al, 1996) Has. As examined
in these studies, the mammalian Has can be divided into at least two
types (Has1 and Has2), and several mammalian cell lines transfected
with their cDNA show markedly increased production of hyaluronan.
The overall structures of both Has1 and Has2 are strikingly similar to
Streptococcus hyaluronan synthase (hasA), Xenopus developmental protein
DG42, and several other molecules possessing N-acetylglucosaminyl
transferase activity. It has been shown that the recombinant hasA
protein from Escherichia coli can synthesize hyaluronan (DeAngelis and
Wigel, 1994) and that expression of DG42 in mammalian cells leads
to the synthesis of hyaluronan (Meyer and Kreil, 1996). The membrane
extracts from yeast expressing DG42 also can synthesize hyaluronan
(DeAngelis and Achyuthan, 1996). Thus, these findings suggest that
both Has1 and Has2 themselves possess hyaluronan synthase activity
or are at least crucial components of hyaluronan synthase. Although
Has1 and Has2 mRNA have been detected in some tissues by northern
blot analyses (Itano and Kimata, 1996b; Shyjian et al, 1996; Spicer et al,
1996), expression of Has1 and Has2 mRNA in skin tissues remains
unknown. Moreover, factors to modulate the expression have not
been investigated.
In this study, we describe the in situ expression of Has1 and Has2
mRNA in mouse skin and the effects of TGF-β on their expression
in cultured human skin fibroblasts and keratinocytes with northern
blot analyses.
MATERIALS AND METHODS
Materials Human skin fibroblasts (Detroit 551) were obtained from American
Type Culture Collection (ATCC No. CCL110), human normal epidermal
VOL. 110, NO. 2 FEBRUARY 1997 EXPRESSION OF HYALURONAN SYNTHASE GENES 117
keratinocytes and bovine pituitary extracts (BPE) from Kurabo (Osaka, Japan),
and male hairless mice (Hos/HR-1) from Nippon SLC (Shizuoka, Japan).
Eagle’s minimum essential medium, nonessential amino acids, and sodium
pyruvate were obtained from Dainippon Pharmaceutical (Osaka, Japan), fetal
bovine serum from JRH Biosciences (Kansas, USA), and MCDB153 medium
and insulin from Wako Pure Chemical Industries (Osaka, Japan). Epidermal
growth factor was purchased from Sigma, hydrocortisone from Merck, 2-
aminoethanol from Nacalai Tesque (Kyoto, Japan), and O-phosphorylethanol-
amine from Tokyo Kasei (Tokyo, Japan). Oligotex-dT30 was obtained from
Takara Shuzou (Kyoto, Japan), recombinant human TGF-β1 from R&D Systems
(Mississippi, USA), SuperScriptTM II from Gibco BRL (Maryland, USA),
GeneAmp PCR Kit from Perkin Elmer (Chiba, Japan), digoxigenin (DIG)
RNA labeling kit, DIG nucleic acid detection kit, anti-DIG alkaline phosphatase
conjugate, and positively charged nylon membrane from Boehringer Mannheim
(Mannheim, Germany), RNaid Kit from Bio101 (California, USA), and human
glyceraldehyde-3-phosphate dehydrogenase (G3PDH) cDNA from Clontec
(California, USA).
Cell culture Human skin fibroblasts were routinely grown in minimum
essential medium supplemented with nonessential amino acids, 1 mM sodium
pyruvate, and 10% (vol/vol) fetal bovine serum. At 3 d after being seeded in
75 cm2 flasks (4.5 3 105 cells per flask), subconfluent cells were harvested for
RNA extraction (see Fig 3 later). For stimulation studies of TGF-β, cells were
seeded as above, and after 4 d the medium was changed to the same, except
that fetal bovine serum was removed (cells were 90% confluent). At 22 h after
the medium change, TGF-β was added to the medium at 0.1–10 ng per ml,
and then total RNA was extracted from the cells at various times.
Human epidermal keratinocytes were routinely grown in MCDB153 (0.1 mM
Ca11) supplemented with 5 mg insulin per liter, 180 µg hydrocortisone per
liter, 6.1 mg 2-aminoethanol per liter, 14.1 mg O-phosphorylethanolamine per
liter, 100 ng epidermal growth factor per liter, and 0.4% (vol/vol) BPE. At 4 d
after being seeded in 90 mm dishes (4 3 105 cells per dish), subconfluent cells
were harvested for RNA extraction (see Fig 3 later). For stimulation studies
of TGF-β, cells were seeded as above, and after 5 d the medium was changed
to the same, except that epidermal growth factor and BPE were removed (cells
were 90% confluent). At 22 h after the medium change, TGF-β was added to
the medium at 0.1–10 ng per ml, and then total RNA was extracted from
the cells.
Has1 and Has2 cDNA isolation The cDNA for mouse Has1 and Has2
(mHas1 and mHas2) and human Has1 and Has2 (hHas1 and hHas2) were
generated using RT-PCR and second PCR (Fig 1). The following primers were
designed for RT-PCR: sense primer, 59-CTTTCAAGGCACTGGGCGAC-39,
and anti-sense primer, 59-CACCGCTTCATAGGTCATCC-39, for mHas1
(Itano and Kimata, 1996a); sense primer, 59-CTGTGAAAAGGCTGACCTAC-
39, and anti-sense primer, 59-TCAGTAAGGCACTTGGACCG-39, for mHas2
(Spicer et al, 1996); sense primer, 59-GCGCGAGGTCATGTACACAG-39,
and anti-sense primer, 59-GTAGAACAGACGCAGCACAG-39, for hHas1
(Itano and Kimata, 1996b); and sense primer, 59-ATGTACACAGCCTTCAG-
AGC-39, and anti-sense primer, 59-TCGCTTCGTAGGTCATCCAC-39, for
hHas2 (Watanabe and Yamaguchi, 1996). The expected fragments correspond
to the nucleotide sequences 680–1233 for mHas1, 314–1016 for mHas2, 540–
1167 for hHas1, and 580–1141 for hHas2 (number is 11 at translational start
position). Total RNA from Detroit 551 for hHas and mouse skin for mHas
was used for RT-PCR. PCR parameters included denaturation at 94°C for
1 min, annealing at 60°C for 2 min, and elongation at 72°C for 2 min for 30
cycles. The expected cDNA fractions were used as templates for the second
PCR. The following primers were designed for the second PCR: sense primer,
59-GGAAAGCTTGACTCAGACACAAGAC-39, and anti-sense primer, 59-
AGGGAATTCGTATAGCCACTCTCGG-39, for mHas1; sense primer, 59-
GGAAAGCTTAACTCAGACGACGACC-39, and anti-sense primer, 59-CG-
TCACCAAAACTGCATTGG-39, for mHas2; sense primer, 59-GGAAAGCT-
TCTGTGACTCGGACAC-39, and anti-sense primer, 59-AGGGAA-
TTCGTACAGCCACTCACGG-39, for hHas1; and sense primer, 59-GGAAA-
GCTTGATTCAGACACTATGC-39, and anti-sense primer, 59-AGGGAAT-
TCGTACAGCCATTCTCGG-39, for hHas2. The expected fragments
correspond to the nucleotide sequences 723–1182 for mHas1, 367–940 for
mHas2, 599–1062 for hHas1, and 633–1092 for hHas2. The underlined
sequences correspond to the restriction sites for HindIII and EcoRI. The second
PCR parameters were the same as described above. The isolated cDNA were
digested with HindIII/EcoRI (for mHas2, internal EcoRI site at nucleotide
position 908 was used) and then ligated into the HindIII/EcoRI site of pSPT18
(Boehringer). The nucleotide sequences of the isolated cDNA were confirmed
to be the authentic Has cDNA by sequencing. DIG-labeled anti-sense/sense
RNA probes were prepared from isolated cDNA using DIG RNA labeling kit.
In situ mRNA hybridization In situ mRNA hybridization was performed
as described previously, with modifications (Igarashi et al, 1995). Sections of
Figure 1. Strategy for isolation of mouse and human Has cDNA. Open
reading frames (ORF) of the cDNA are indicated by open boxes. Highly
conserved regions among the cDNA are indicated by shaded boxes in ORF.
Residues showed to be crucial for the N-acetylglucosaminyltransferase activity
of yeast chitin synthase 2 (Nagahashi et al, 1995) were completely conserved in
this region. Mouse and human Has cDNA were generated by RT-PCR and
second PCR. Primers for RT-PCR are indicated by closed triangles, and for
second PCR by open triangles. Arrows represent DIG-labeled anti-sense RNA
probes. The bold numbers indicate nucleotide positions of primers used for
second PCR (translational start position at 11).
skin tissues from male hairless mice (Hos/HR-1; 41 wk old) were used. The
post-fixed sections were acetylated with a triethanolamine buffer (pH 8.0)
containing 0.25% acetic anhydride for 10 min. Blocking reagent (Boehringer)
was added to the hybridization buffer at 2% (wt/vol).
DIG-labeled mHas1 and mHas2 anti-sense RNA probes (final 1 µg per ml)
were used to detect Has1 and Has2 mRNA. In control experiments, DIG-
labeled sense RNA probes (final 1 µg per ml) and nonlabeled anti-sense RNA
(100-fold excess) were used. Hybridization was performed in a humidified
chamber at 46°C for 18 h, after which specimens were washed at 46°C for
30 min in 2 3 sodium citrate/chloride buffer with 50% formamide, for 20 min
in 2 3 sodium citrate/chloride buffer, and in 0.2 3 sodium citrate/chloride
buffer twice. After post-hybridization washing, DIG-labeled probes were
visualized with anti-DIG alkaline phosphatase conjugate, 5-bromo-4-chloro-3-
indolylphosphate, and nitroblue tetrazolium chloride according to the manufac-
turer’s protocol. The sections were then mounted.
Northern blot analysis Total RNA and poly (A)1 RNA were isolated using
an RNaid Kit and Oligotex-dT30, respectively. RNA samples were separated
by electrophoresis on 0.8% formaldehyde/agarose gel and transferred onto a
nylon membrane. DIG-labeled hHas1 and hHas2 anti-sense RNA probes were
prepared as above. Hybridization was performed according to DIG Nucleic
Acid Detection Kit’s protocol.
The chemiluminescent detection was performed as described previously
(Engler-Blum et al, 1993). The membranes were washed at 95°C for 3 min in
0.1% sodium dodecyl sulfate, cooled to room temperature, and rehybridized
with a DIG-labeled G3PDH anti-sense RNA probe.
RESULTS
Has1 and Has2 mRNA are expressed in mouse dermis and
epidermis We have examined the expression of Has1 and Has2
mRNA in mouse skin using in situ mRNA hybridization (Fig 2). In
dermis, both Has1 and Has2 mRNA were detected, and the number of
the cells expressing Has1 mRNA was less than that of Has2 mRNA
(Fig 2a,b), indicating that fibroblasts in dermis are heterogeneous in
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Figure 2. Has1 and Has2 mRNA are expressed in normal mouse skin. Skin specimens from 41 wk old male hairless mice were analyzed by in situ
hybridization. DIG-labeled RNA probes were used as follows: (a) DIG-labeled mHas1 anti-sense RNA probe, (b) DIG-labeled mHas2 anti-sense RNA probe, (c)
DIG-labeled sense mHas1 probe, (d) DIG-labeled mHas1 anti-sense RNA probe in the presence of an excess nonlabeled mHas1 anti-sense RNA, (e) DIG-labeled
mHas1 anti-sense RNA probe in the presence of an excess nonlabeled mHas2 anti-sense RNA, (f) DIG-labeled sense mHas2 probe, (g) DIG-labeled mHas2 anti-
sense RNA probe in the presence of an excess nonlabeled mHas2 anti-sense RNA, (h) DIG-labeled mHas2 anti-sense RNA probe in the presence of an excess
nonlabeled mHas1 anti-sense RNA. Results shown are taken from one representative experiment repeated two times. Scale bars, 50 µm.
expression of Has1 mRNA. In epidermis, both Has1 and Has2 mRNA
were abundantly expressed in the basal layer to granular cells, and some
strong signals from both mRNA were seen in stratum granulosum
(Fig 2a,b), suggesting that both mRNA express concomitantly.
The DIG-labeled sense RNA probes showed low background
(Fig 2c,f), and an excess nonlabeled Has1 or Has2 anti-sense RNA
markedly decreased the signals from the corresponding DIG-labeled
Has probe to the background (Fig 2d,g). In cross-hybridization
experiments, the excess non-labeled RNA could not prevent binding
of the DIG-labeled probes (Fig 2e,h). These findings indicate that
signals derived from DIG-labeled mHas1 and mHas2 anti-sense RNA
probes are specific.
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Figure 3. Has1 and Has2 mRNA are expressed in cultured human skin
fibroblasts and keratinocytes. Poly (A)1 RNA extracted from subconfluent
cells was used for northern blot analyses. Equal amounts of the samples (2 µg
per lane) from fibroblasts (lane 1) and keratinocytes (lane 2) were separated by
electrophoresis and then transferred onto nylon filters. The filters were probed
with DIG-labeled hHas1 and hHas2 anti-sense RNA probes. After washing the
probes, the filters were exposed to X-ray films for 10 min. Overexposure to
X-ray films showed slight signals for Has2 mRNA in keratinocytes (data
not shown).
Has1 and Has2 mRNA are expressed in cultured human skin
fibroblasts and keratinocytes Poly (A)1 RNA prepared from sub-
confluent cells was analyzed by northern blotting using either DIG-
labeled human Has1 or Has2 anti-sense RNA probe (Fig 3). Has1
mRNA was detected in both fibroblasts and keratinocytes, but as a
different single band with a size of 2.4 and 4.8 kb, respectively (Fig 3,
left). Has2 mRNA was detected abundantly in fibroblasts as two bands
of 3.2 and 4.8 kb, but as a trace of bands in keratinocytes under the
conditions (Fig 3, right). Thus, the expression patterns of Has1 and
Has2 mRNA were different between cultured human fibroblasts and
keratinocytes.
Induction of Has genes expression by TGF-β in cultured human
skin fibroblasts and keratinocytes It has been shown that the syn-
thesis of hyaluronan in human cultured fibroblasts is stimulated by TGF-
β (Heldin et al, 1989; Suzuki et al, 1995). We observed that cultured
fibroblasts accumulate Has1 mRNA of 2.4 kb and Has2 mRNA of 3.2
and 4.8 kb (Fig 3). To investigate whether or not TGF-β upregulates
expression of Has1 and Has2 mRNA, total RNA extracted from
fibroblasts stimulated with TGF-β was subjected to
northern blot analyses. Stimulation of fibroblasts with 0.1–10 ng TGF-β
per ml for 4 h resulted in a marked increase of both Has1 and Has2
mRNA (Fig 4a). Maximal accumulation of the Has2 mRNA on
stimulation with 1 ng TGF-β per ml increased about 10-fold over the
control when the density of the bands was analyzed using an NIH Image
(available from the Internet by anonymous ftp from zippy.nimh.nih.gov;
data not shown).
When fibroblasts were stimulated with 1 ng TGF-β per ml for
various periods, upregulation of expression of both Has1 and Has2
mRNA was observed as early as 2 h after stimulation (Fig 4b). The
amount of upregulated Has1 mRNA slightly decreased at 4 h after
stimulation and markedly increased at 18 h, whereas the amount of
upregulated Has2 mRNA was maximal at 6 h after stimulation and
slightly decreased at 18 h. These findings indicate that Has1 and Has2
genes are regulated by TGF-β independently.
We have shown that cultured keratinocytes accumulated Has1
mRNA of 4.8 kb (Fig 3). When keratinocytes were stimulated with
0.1–10 ng TGF-β per ml for 4 h, 2.4 kb Has1 mRNA, which was
the same in size as the single band observed in fibroblasts, was induced,
although 4.8 kb Has1 mRNA was not upregulated (Fig 5a). The level
of 2.4 kb Has1 mRNA expression maximal at 2 h after TGF-β addition
was decreased time-dependently to the nonstimulated level at 18 h
Figure 4. The expression of Has1 and Has2 mRNA is upregulated by
TGF-β in cultured human skin fibroblasts. (a) Fibroblasts were cultured in
the presence of 0–10 ng TGF-β per ml. After 4 h, cells were lysed and total
RNA was extracted. As a control, total RNA was extracted from the cells just
before adding TGF-β. Equal amounts of total RNA (5 µg per lane) were used
for northern blot analyses. The filters were first hybridized with either hHas1
or hHas2 probe and then rehybridized with G3PDH probe. (b) Fibroblasts
were cultured in the absence or presence of TGF-β (1 ng per ml) for various
times. Total RNA was analyzed as above. Results shown are taken from one
representative experiment repeated two times.
(Fig 5b), indicating that keratinocytes have no late phase of TGF-β-
induced Has1 mRNA expression as observed in fibroblasts (Fig 4b).
Northern blot analyses using poly (A)1 RNA showed the same results
as above, and Has2 mRNA were not upregulated by TGF-β (data not
shown). These findings suggest that, for expression of Has1 and Has2
genes, fibroblasts have a higher response to TGF-β than keratinocytes.
DISCUSSION
We have shown the expression of both Has1 and Has2 mRNA in
mouse skin using in situ mRNA hybridization (Fig 2). In dermis, the
number of the cells expressing the Has1 mRNA was less than that of
the cells expressing the Has2 mRNA. The Has2 mRNA appeared to
be expressed in almost all the fibroblasts because the distribution of
the signals from the Has2 mRNA corresponded to that of the cells
stained with hematoxylin (data not shown). Thus, fibroblasts appear
to be heterogeneous in the expression of the Has1 mRNA, whereas
they express Has2 mRNA constitutively.
Although both Has1 and Has2 mRNA were abundantly expressed
in mouse epidermis (Fig 2), Has2 mRNA were detected as a trace of
bands in cultured human keratinocytes under normal growth conditions
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Figure 5. The expression of Has1 mRNA of 2.4 kb but not 4.8 kb is
upregulated by TGF-β in cultured human keratinocytes. (a) Keratinocytes
were cultured in the presence of 0–10 ng TGF-β per ml. After 4 h, cells were
lyzed and total RNA was extracted. As a control, total RNA was extracted
from the cells just before adding TGF-β. Equal amounts of total RNA (5 µg
per lane) were used for northern blot analyses. The filters were first hybridized
with hHas1 probe and then rehybridized with G3PDH probe. (b) Keratinocytes
were cultured in the absence or presence of TGF-β (1 ng per ml) for various
times. Total RNA was analyzed as above. Results shown are taken from one
representative experiment repeated two times.
(Fig 3, right). It is known that the growth phase (Brecht et al, 1986;
Matuoka et al, 1987; Kitchen and Cysyk, 1995), cell type (Westergren-
Thorsson et al, 1990), and presumably the immediate environment of
the cells markedly influence the synthesis of hyaluronan. Some strong
signals from Has1 and Has2 mRNA were observed in mouse stratum
granulosum (Fig 2), suggesting that expression of Has genes participates
in differentiation of keratinocytes. Other culture conditions of ker-
atinocytes to induce Has2 gene expression must be examined.
Has1 mRNA size was different between cultured human fibroblasts
and keratinocytes: 2.4 kb in fibroblasts and 4.8 kb in keratinocytes
(Fig 3). Moreover, TGF-β upregulated expression of 2.4 kb Has1
mRNA in both cultures but not that of 4.8 kb Has1 mRNA in
keratinocytes (Fig 5). Two laboratories have cloned the cDNA
encoding for human Has1 (Itano and Kimata, 1996b; Shyjian et al,
1996), which are only different in 59-termini. In their studies, the two
distinct sizes of the Has1 mRNA were detected in some human tissues,
e.g., both 2.4 and 4.8 kb Has1 mRNA were in heart, 2.4 kb Has1
mRNA in ovary, and 4.8 kb Has1 mRNA in skeletal muscle as a
major transcript. Furthermore, a genomic Southern blot analysis showed
that the Has1 gene is a single copy (Shyjian et al, 1996). Taken together,
expression of Has1 gene in cultured keratinocytes and fibroblasts might
be regulated by distinct promoters. Similar cases have been reported
for the human dystrophin gene (Boyce et al, 1992; Hugnot et al, 1992),
human platelet-activating factor gene (Mutoh et al, 1993), and mouse
glucocorticoid receptor gene (Stra¨hle et al, 1992). Such promoters
could have different cell type-specific activities on gene expression.
There is still the possibility that cell type-specific alternative splicing
is responsible for expression of Has1 mRNA in cultured fibroblasts
and keratinocytes. To clarify the mechanism of the Has1 gene expression
in detail, further investigations are required, such as genomic cloning,
primer extension, and promoter analysis.
Has2 mRNA were also detected as two bands of 3.2 and 4.8 kb in
fibroblasts (Fig 3). The sizes of the two mRNA were identical to
those detected in human lung fibroblasts, IMR-90 (data not shown),
which accumulate Has2 mRNA (Watanabe and Yamaguchi, 1996). It
has been shown that the two sizes of Has2 mRNA are detected in
some mouse tissues, and mouse Has2 gene is a single copy (Spicer
et al, 1996). Our findings showed that TGF-β upregulated Has2
mRNA of both 3.2 and 4.8 kb with no change in the ratio (the ratio
of 4.8 kb to 3.2 kb Has2 mRNA was 1.7). Thus, as suggested by
Spicer et al, the two distinct forms of Has2 mRNA might be generated
using alternative polyadenylation signals in the 39-untranslated region
rather than using a dual promoter or alternative splicing.
The synthesis of hyaluronan has been known to be stimulated by
TGF-β (Heldin et al, 1989, 1992; Suzuki et al, 1995). Our studies
showed that, in cultured human fibroblasts, both Has1 and Has2
mRNA were upregulated (Fig 4), and the synthesis of hyaluronan was
also stimulated by TGF-β (data not shown), suggesting that stimulation
of hyaluronan synthesis by TGF-β involves upregulation of Has genes.
It should be noted that the effect of TGF-β on expression of Has1
and Has2 mRNA revealed different time dependency, in which the
peak for the amount of upregulated Has2 mRNA was observed earlier
than that for Has1 mRNA (Fig 4b). It has been described that the
effect of TGF-β on hyaluronan synthase activity occurs later than that
of PDGF-BB in normal human mesothelial cells, suggesting that TGF-β
induces some factors that in turn stimulate hyaluronan synthesis (Heldin
et al, 1992). Our findings support this possibility, and the factors induced
by TGF-β may have a crucial role on expression of Has1 mRNA.
In cultured keratinocytes, TGF-β induced Has1 mRNA of 2.4 kb
(Fig 5a), which was detected as a single band in fibroblasts (Fig 3, of
4.8 kb to 3.2 kb Has2 mRNA was 1.7). Thus, as suggested by 2 h
after stimulation was decreased time-dependently to the nonstimulated
level at 18 h (Fig 5b), although 18 h stimulation of fibroblasts by
TGF-β was more effective on upregulation of the Has1 mRNA than
2 h stimulation (Fig 4b). This difference may be related to the autocrine
factors induced by TGF-β as mentioned above. Identifying than 2 h
stimulation (Fig 4b). This difference may be related to the may be
useful for elucidating the regulation of hyaluronan biosynthesis.
In summary, our findings revealed that expression patterns of Has1
and Has2 mRNA in mouse skin and cultured human skin cells are
different. Furthermore, their expression is regulated independently,
suggesting that hyaluronan from Has1 or Has2 may have distinct
functions or may be expressed for distinct purposes at a different
time. In psoriasis and scleroderma, elevated levels of hyaluronan
concentrations were found in interstitial fluid from skin (Juhlin et al,
1986; Lundin et al, 1987). The increased concentrations of hyaluronan
may partly result from overexpression of either or both Has genes.
Further studies to investigate the expression of Has genes and its
relationship to skin disorders as well as aging and wound healing would
help clarify the functions of hyaluronan in dermis and epidermis.
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